Description
Bimatoprost, also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic
structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution
and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular
hypertension and glaucoma. Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth.It was
initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash
growth became a desirable adverse effect for patients using this drug.
Bimatoprost is a medicine that treats high pressure in the eye (ocular hypertension) and helps with glaucoma.High
pressure can happen when too much fluid builds up inside your eye. Bimatoprost helps to drain the fluid.If not treated,
high pressure can damage your optic nerve and cause vision loss or blindness.Bimatoprost is available on prescription only.
Bimatoprost eye drops come in bottles or single-dose droppers. Some bottled eye drops contain a preservative
(benzalkonium chloride), to keep the eye drops sterile.
Application&Function
Bimatoprost is used for the reduction of elevated intraocular pressure in patients with open-angle glaucoma
or ocular hypertension.
These patients must be intolerant to other intraocular pressure lowering medications or inadequately responsive
to other treatments.
Bimatoprost is also indicated to treat eyelash hypotrichosis.
China
